Tetracycline Hydrochloride Capsule
Product Images NDC 0591-2475

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tetracycline Hydrochloride (NDC 0591-2475). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

This appears to be the chemical formula and molecular weight of a compound, but it is not possible to provide a useful description or name without additional information.*

FDA Label Image

Image 2

Each capsule with NDC number 0591-2474-01 contains 250mg of Tetracycline Hydrochloride. The capsules are controlled on temperature and packed with child-resistant closure. These capsules are manufactured by Actavis in New Jersey, USA.*

FDA Label Image

Image 3

This is a medication with the NDC code 0591-2475-01, containing Tetracycline Hydrochloride USP in the amount of 500 mg per capsule. It should be dispensed with a child-resistant cap and stored in a container that is light-resistant and tight. The usual dosage is available in the package brochure. It should be stored at a temperature of 20° to 25°C (68° to 77°F) and kept in a controlled room temperature per the USP guidance. This medication is manufactured by Watson Pharma Private Limited with a total of 100 capsules per container. It is distributed by RxOnly Actavis Pharma, Inc. located in Parsippany, NJ 07054, USA. The Lot number is indicated below the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.